CLOCK and neoplasm: Genetic and genomic investigations of malignancies have revealed that changes in clock gene expression are more common than clock gene mutations, leading to the concept that oncogenic programs can disrupt circadian regulation, further complicating and stimulating tumor growth [45,48].